DBV Technologies Valuation

DBV Stock  EUR 0.80  0.01  1.23%   
Today, the entity appears to be overvalued. DBV Technologies shows a prevailing Real Value of €0.68 per share. The current price of the entity is €0.8. Our model computes the value of DBV Technologies from examining the entity fundamentals such as Shares Outstanding of 93.97 M, operating margin of (8.04) %, and Return On Asset of -0.22 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
0.80
Please note that DBV Technologies' price fluctuation is out of control at this time. Calculation of the real value of DBV Technologies is based on 3 months time horizon. Increasing DBV Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DBV Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DBV Stock. However, DBV Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.8 Real  0.68 Hype  0.8 Naive  0.6
The real value of DBV Stock, also known as its intrinsic value, is the underlying worth of DBV Technologies Company, which is reflected in its stock price. It is based on DBV Technologies' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DBV Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.68
Real Value
9.61
Upside
Estimating the potential upside or downside of DBV Technologies SA helps investors to forecast how DBV stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DBV Technologies more accurately as focusing exclusively on DBV Technologies' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.490.761.03
Details
Hype
Prediction
LowEstimatedHigh
0.040.809.73
Details
Naive
Forecast
LowNext ValueHigh
0.010.609.52
Details

DBV Technologies Total Value Analysis

DBV Technologies SA is currently anticipated to have takeover price of 51.36 M with market capitalization of 269.31 M, debt of 12.8 M, and cash on hands of 125.48 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DBV Technologies fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
51.36 M
269.31 M
12.8 M
125.48 M

DBV Technologies Investor Information

About 33.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.24. Some equities with similar Price to Book (P/B) outperform the market in the long run. DBV Technologies recorded a loss per share of 1.04. The entity had not issued any dividends in recent years. Based on the key indicators related to DBV Technologies' liquidity, profitability, solvency, and operating efficiency, DBV Technologies SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

DBV Technologies Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DBV Technologies has an asset utilization ratio of 3.89 percent. This suggests that the Company is making €0.0389 for each dollar of assets. An increasing asset utilization means that DBV Technologies SA is more efficient with each dollar of assets it utilizes for everyday operations.

DBV Technologies Ownership Allocation

DBV Technologies holds a total of 93.97 Million outstanding shares. 30% of DBV Technologies SA outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Thus, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.

DBV Technologies Profitability Analysis

The company reported the revenue of 5.71 M. Net Loss for the year was (97.81 M) with profit before overhead, payroll, taxes, and interest of 5.71 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DBV Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DBV Technologies and how it compares across the competition.

About DBV Technologies Valuation

The stock valuation mechanism determines DBV Technologies' current worth on a weekly basis. Our valuation model uses a comparative analysis of DBV Technologies. We calculate exposure to DBV Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DBV Technologies's related companies.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV TECHNOLOGIES operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 97 people.

8 Steps to conduct DBV Technologies' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DBV Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DBV Technologies' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain DBV Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine DBV Technologies' revenue streams: Identify DBV Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research DBV Technologies' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish DBV Technologies' growth potential: Evaluate DBV Technologies' management, business model, and growth potential.
  • Determine DBV Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DBV Technologies' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for DBV Stock analysis

When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stocks Directory
Find actively traded stocks across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world